Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VizionfocusTPE:4771 -0.49%91 FCF Margin % is -20.84% as of Dec. 2025. GuruFocus rates TPE:4771 with a GF Score™ of 91/100 and a GF Value™ of NT$294.76 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 817 Medical Devices & Instruments companies, Vizionfocus ranks worse than 57.28% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vizionfocus's Free Cash Flow for the
three
months ended in Dec. 2025 was NT$-198 Mil. Vizionfocus's Revenue for the
three
months ended in Dec. 2025 was NT$951 Mil. Therefore, Vizionfocus's FCF Margin % for the quarter that ended in Dec. 2025 was -20.84%.
The historical rank and industry rank for Vizionfocus's FCF Margin % or its related term are showing as below:
TPE:4771'
s FCF Margin % Range Over the Past 10 Years
Min: -62.14 Med: -10.44 Max: 25.39
Current: -3.95
During the past 8 years, the highest FCF Margin % of Vizionfocus was 25.39%. The lowest was -62.14%. And the median was -10.44%.
TPE:4771's FCF Margin % is ranked worse than 57.28% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: -0.54
vs TPE:4771: -3.95
Vizionfocus FCF Margin % Related Terms
Vizionfocus FCF Margin % Historical Data
* Premium members only.
The historical data trend for Vizionfocus's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4771 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Vizionfocus's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vizionfocus FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vizionfocus's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Vizionfocus's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vizionfocus (TPE:4771) has a FCF Margin % of -20.84% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vizionfocus and its competitors. According to the industry distribution chart, Vizionfocus ranks #468 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 57.3%.
Is Vizionfocus' FCF Margin % too high?
Vizionfocus' current FCF Margin % is -20.84%. Based on the distribution chart, Vizionfocus ranks #468 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Vizionfocus has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vizionfocus' FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Vizionfocus ranks #468 out of 817 companies for FCF Margin %. This places Vizionfocus in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vizionfocus and its competitors. Vizionfocus's current FCF Margin % is -20.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vizionfocus stock overvalued right now?
Based on GuruFocus' analysis, Vizionfocus (TPE:4771) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$294.76, compared to a current price of NT$203.00 — trading 31.1% below its estimated fair value. The current FCF Margin % is -20.84%. Vizionfocus' overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vizionfocus (TPE:4771), the current FCF Margin % is -20.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vizionfocus (TPE:4771) Overvalued in 2026?
Based on GuruFocus' analysis, Vizionfocus stock appears to be undervalued.
The current stock price of NT$203.00 is trading 31.1% below its estimated GF Value™ of NT$294.76.
GuruFocus considers Vizionfocus to be Significantly Undervalued.
Key valuation signals for TPE:4771:
FCF Margin %: -20.84%
GF Value™: NT$294.76 vs. price of NT$203.00 (31.1% below fair value)
No single metric tells the full story. See the TPE:4771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vizionfocus Inc is mainly engaged in the manufacturing of medical equipment, machinery and equipment, optical instruments, precision instruments, international trading, and other consulting services. The Company operates through the VIZIONFOCUS segment, which generates maximum revenue and is engaged in the manufacturing of medical equipment, machinery and equipment, optical instruments, precision instruments, international trading, and other consulting services, and the Jiangsu Vizionfocus Inc. segment, whose main business includes the research and development, design, and production of contact lenses, as well as the wholesale, import, and export of related products.
91GF Score
Get the complete analysis for TPE:4771
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4771 has been successfully added to your 
